Quantum Cyber N.V.

QUCY ·Healthcare, Drug Manufacturers - General
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Operating Activities
Net Income $-16.2M $-21.6M $-26.3M $-26.4M $-11.7M $-586.9K $-957.1K
Depreciation & Amortization $615.7K $696.6K — — — — —
Depreciation $238.5K $319.5K — — — — —
Amortization $377.2K $377.2K $377.2K — — — —
Stock-Based Compensation $1.5M $-63.1K — — — — —
Net Cash from Operating Activities $-11.0M $-17.3M $-21.9M $-14.8M $-3.2M $-468.7K $-416.5K
Investing Activities
Capital Expenditures $1.2K $104.9K $1.2M $658.5K $16.7K $9.7K —
Business Acquisitions — — — — — — —
Net Cash from Investing Activities $-1.0M $-198.8K $-1.9M $-658.5K $1.2M $-9.7K —
Financing Activities
Dividends Paid — — — — — — —
Stock Repurchases — — — — — — —
Net Cash from Financing Activities $6.8M $16.8M $14.2M $23.9M $10.6M $396.7K $424.0K
Net Change in Cash $-5.3M $-835.3K $-10.1M $8.4M $8.6M $-81.0K $7.5K
Free Cash Flow $-11.0M $-17.4M $-23.1M $-15.4M $-3.2M $-478.4K —